Association between neopterin and carotid intima-media thickness in hemodialysis patients

Nephron - Clinical Practice

Volumn 101, Issue 3, 2005, Pages

  Erten, Yasemin ^a   Öztürk, M Akif ^a,b   Oktar, Suna ^a   Pasaoglu, Hatice ^a   Reis, Kadriye Altok ^a   Derici, Ülver ^a   Elbeg, Sehri ^a   Güz, Galip ^a   Bali, Musa ^a   Arinsoy, Turgay ^a   Sindel, Sükrü ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Atherosclerosis; Carotid intima media thickness; High resolution B mode ultrasonography; Neopterin

Indexed keywords

NEOPTERIN;

ADULT; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; THICKNESS;

ADULT; AGED; ATHEROSCLEROSIS; CAROTID ARTERIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NEOPTERIN; RENAL DIALYSIS; TUNICA INTIMA;

EID: 27544516001     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086684     Document Type: Article

References (23)

1. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
2. Kawagishi T, Nishizawa Y, Konishi T, Kawasaki K, Emoto M, Shoji T, Tabata T, Inoue T, Morii H: High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 1995;48:820-826.
3. Kennedy R, Case C, Fathi R, Johnson D, Isbel N, Marwick TH: Does renal failure cause an atherosclerotic milieu in patients with endstage renal disease? Am J Med 2001;110:198-204.
4. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C: Prognostic value of ultrasonographic measurement of carotid intima-media thickness in dialysis patients. J Am Soc Nephrol 2001;12:2458-2464.
5. Hojs R: Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs 2000;24:691-695.
6. Libby P, Hansson GK: Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions. Lab Invest 1991;64:5-15.
7. Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA: Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003;89:993-997.
8. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W: Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest 1997;100:2680-2690.
9. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H: Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-γ. J Exp Med 1984;160:310-316.
10. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER: Neopterin as a marker for activation of cellular immunity: Immunologic basis and clinical application. Adv Clin Chem 1989;27:81-141.
11. Fuchs D, Weiss G, Wachter H: Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol 1993;101:1-6.
12. Weiss G, Willeit J, Kiechl S, Fuchs D, Jarosch E, Oberhollenzer F, Reibnegger G, Tilz GP, Gerstenbrand F, Wachter H: Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 1994;106:263-271.
13. Gurfinkel EP, Scirica BM, Bozovich G, Macchia A, Manos E, Mautner B: Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol 1999;83:515-518.
14. Tatzber F, Rabl H, Koriska K, Erhart U, Puhl H, Waeg G, Krebs A, Esterbauer H: Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 1991;89:203-208.
15. Godai K, Uemasu J, Kawasaki H: Clinical significance of serum and urinary neopterins in patients with chronic renal disease. Clin Nephrol 1991;36:141-146.
16. Yokoyama K, Tajima M, Yoshida H, Nakayama M, Tokutome G, Sakagami H, Hosoya T: Plasma pteridine concentrations in patients with chronic renal failure. Nephrol Dial Transplant 2002;17:1032-1036.
17. Kato A, Odamaki M, Takita T, Maruyama Y, Kumagai H, Hishida A: Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients. Kidney Int 2002;61:1143-1152.
18. Hoffmann G, Wirleitner B, Fuchs D: Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 2003;52:313-321.
19. Herpfer I, Greilberger J, Ledisnki G, Widner B, Fuchs D, Jurgens G: Neopterin and 7,8-dihydroneopterin interfere with low density lipoprotein oxidation mediated by peroxynitrite and/or copper. Free Radic Res 2002;36:509-520.
20. Stenvinkel P, Heimburger O, Jogestrand T: Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity. Am J Kidney Dis 2002;39:274-282.
21. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000;148:209-214.
22. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767-1772.
23. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A: Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003;64:1472-1479.